source
- FDA greenlights Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has approved a new therapy from Vera Therapeutics aimed at treating IgA nephropathy, a chronic autoimmune kidney disorder. The drug, called Trutakna, is intended for patients with this con…
- Vertex to acquire Crinetics in $10 billion deal, expanding rare endocrine disorder pipelineVertex announced on July 7, 2026 that it will acquire Crinetics Pharmaceuticals for $10 billion, marking the company’s largest-ever transaction. Crinetics is a biotech focused on developing treatm…